Liszkay G - Search Results

1

Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma.

Ladányi A, Papp E, Mohos A, Balatoni T, Liszkay G, Oláh J, Varga A, Lengyel Z, Emri G, Ferrone S. Ladányi A, et al. Among authors: liszkay g. J Immunother Cancer. 2020 Jun;8(1):e000209. doi: 10.1136/jitc-2019-000209. J Immunother Cancer. 2020. PMID: 32554608 Free PMC article.

2

Serum concentration of 5-S-cysteinyldopa in patients with melanoma.

Bánfalvi T, Gilde K, Boldizsár M, Fejös Z, Horváth B, Liszkay G, Beczássy E, Kremmer T. Bánfalvi T, et al. Among authors: liszkay g. Eur J Clin Invest. 2000 Oct;30(10):900-4. doi: 10.1046/j.1365-2362.2000.00710.x. Eur J Clin Invest. 2000. PMID: 11029605

3

FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma.

Ladányi A, Mohos A, Somlai B, Liszkay G, Gilde K, Fejos Z, Gaudi I, Tímár J. Ladányi A, et al. Among authors: liszkay g. Pathol Oncol Res. 2010 Sep;16(3):303-9. doi: 10.1007/s12253-010-9254-x. Epub 2010 Mar 21. Pathol Oncol Res. 2010. PMID: 20306313 Free article.

4

[Epidemiology of malignant melanoma (Clinical experience at the National Institute of Oncology in Hungary)].

Balatoni T, Liszkay G, Miklós Z, Kásler M. Balatoni T, et al. Among authors: liszkay g. Orv Hetil. 2011 Jun 19;152(25):1000-6. doi: 10.1556/OH.2011.29148. Orv Hetil. 2011. PMID: 21642052 Hungarian.

5

Prognostic impact of B-cell density in cutaneous melanoma.

Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejös Z, Gaudi I, Dobos J, Tímár J. Ladányi A, et al. Among authors: liszkay g. Cancer Immunol Immunother. 2011 Dec;60(12):1729-38. doi: 10.1007/s00262-011-1071-x. Epub 2011 Jul 21. Cancer Immunol Immunother. 2011. PMID: 21779876 Free PMC article.

6

[The importance of fine needle aspiration cytology in the management of recurrent and metastatic melanoma].

Pánczél G, Liszkay G, Borbola K, Balatoni T, Hunyadi J. Pánczél G, et al. Among authors: liszkay g. Orv Hetil. 2012 Sep 9;153(36):1419-23. doi: 10.1556/OH.2012.29434. Orv Hetil. 2012. PMID: 22951409 Hungarian.

7

Immune cell profile of sentinel lymph nodes in patients with malignant melanoma - FOXP3+ cell density in cases with positive sentinel node status is associated with unfavorable clinical outcome.

Mohos A, Sebestyén T, Liszkay G, Plótár V, Horváth S, Gaudi I, Ladányi A. Mohos A, et al. Among authors: liszkay g. J Transl Med. 2013 Feb 18;11:43. doi: 10.1186/1479-5876-11-43. J Transl Med. 2013. PMID: 23418928 Free PMC article.

8

[New TNM classification (AJCC 2009) and the pathological significance of sentinel lymph node biopsy in malignant melanoma].

Plótár V, Liszkay G, Ladányi A, Tóth E. Plótár V, et al. Among authors: liszkay g. Magy Onkol. 2013 Jun;57(2):68-72. Epub 2013 May 1. Magy Onkol. 2013. PMID: 23795350 Free article. Review. Hungarian.

9

Psychological changes in melanoma patients during ipilimumab treatment compared to low-dose interferon alpha therapy-a follow-up study of first experiences.

Kovács P, Pánczél G, Borbola K, Juhász G, Liszkay G. Kovács P, et al. Among authors: liszkay g. Pathol Oncol Res. 2014 Oct;20(4):939-44. doi: 10.1007/s12253-014-9777-7. Epub 2014 Apr 27. Pathol Oncol Res. 2014. PMID: 24771289 Free article.

10

Ectopic lymphoid structures in primary cutaneous melanoma.

Ladányi A, Sebestyén T, Mohos A, Liszkay G, Somlai B, Tóth E, Tímár J. Ladányi A, et al. Among authors: liszkay g. Pathol Oncol Res. 2014 Oct;20(4):981-5. doi: 10.1007/s12253-014-9784-8. Epub 2014 Apr 30. Pathol Oncol Res. 2014. PMID: 24781762 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page